Amanda is a member of the CEO and Board practice at Klein Hersh. Having joined in 2021, she partners closely with investors and board members of emerging biotech companies.
As a member of the CEO and Board practice, Amanda’s responsibilities include:
- Partnering with leadership of emerging biotech companies to support the buildout of their executive leadership teams.
- Collaborating with public biotech and venture-backed biotech companies seeking to add independent Board members with a focus on diversifying and complementing the existing Board.